Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
Fond G, Godin O, Brunel L, Aouizerate B, Berna F, Bulzacka E, Capdevielle D, Chereau I, Dorey JM, Dubertret C, Dubreucq J, Faget C, Gabayet F, Le Strat Y, Micoulaud-Franchi JA, Misdrahi D, Rey R, Richieri R, Passerieux C, Schandrin A, Schürhoff F, Tronche AM, Urbach M, Vidalhet P, Llorca PM, Leboyer M; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Fond G, et al. Among authors: aouizerate b. J Affect Disord. 2016 Feb;191:209-15. doi: 10.1016/j.jad.2015.11.017. Epub 2015 Nov 26. J Affect Disord. 2016. PMID: 26674214
Cord serum cytokines at birth and children's trajectories of mood dysregulation symptoms from 3 to 8 years: The EDEN birth cohort.
Herbein M, Barbosa S, Collet O, Khalfallah O, Navarro M, Bailhache M, Iv N, Aouizerate B, Sutter-Dallay AL, Koehl M, Capuron L, Ellul P, Peyre H, Van der Waerden J, Melchior M, Côté S, Heude B, Glaichenhaus N, Davidovic L, Galera C. Herbein M, et al. Among authors: aouizerate b. Brain Behav Immun Health. 2024 Mar 29;38:100768. doi: 10.1016/j.bbih.2024.100768. eCollection 2024 Jul. Brain Behav Immun Health. 2024. PMID: 38586283 Free PMC article.
Factors associated with lamotrigine concentration/dose ratio in individuals with bipolar disorders.
Chouchana M, Delage C, Godin O, Fontan JE, Bellivier F, Gard S, Aubin V, Belzeaux R, Dubertret C, Haffen E, Leboyer M, Olie E, Courtet P, Polosan M, Roux P, Samalin L, Schwan R, Lefrere A, Bloch V, Etain B; FondaMental Advanced Center of Expertise for Bipolar Disorders (FACE-BD). Chouchana M, et al. Eur Neuropsychopharmacol. 2023 Aug;73:75-81. doi: 10.1016/j.euroneuro.2023.04.005. Epub 2023 May 4. Eur Neuropsychopharmacol. 2023. PMID: 38465581
Decreased telomere length in a subgroup of young individuals with bipolar disorders: replication in the FACE-BD cohort and association with the shelterin component POT1.
Spano L, Marie-Claire C, Godin O, Lebras A, Courtin C, Laplanche JL, Leboyer M, Aouizerate B, Lefrere A, Belzeaux R, Courtet P, Olié E, Dubertret C, Schwan R, Aubin V, Roux P, Polosan M, Samalin L, Haffen E; Fondamental Advanced Centers Of Expertise In Bipolar Disorders (Face-Bd) Collaborators; Bellivier F, Etain B. Spano L, et al. Among authors: aouizerate b. Transl Psychiatry. 2024 Mar 1;14(1):131. doi: 10.1038/s41398-024-02824-z. Transl Psychiatry. 2024. PMID: 38429270 Free PMC article.
French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024.
Yrondi A, Javelot H, Nobile B, Boudieu L, Aouizerate B, Llorca PM, Charpeaud T, Bennabi D, Lefrere A, Samalin L. Yrondi A, et al. Among authors: aouizerate b. Encephale. 2024 Feb 17:S0013-7006(24)00019-8. doi: 10.1016/j.encep.2023.11.029. Online ahead of print. Encephale. 2024. PMID: 38369426
Incidence and predictors of metabolic syndrome onset in individuals with bipolar disorders: A longitudinal study from the FACE-BD cohort.
Godin O, Olié E, Fond G, Aouizerate B, Aubin V, Bellivier F, Belzeaux R, Courtet P, Dubertret C, Haffen E, Lefrere A, Llorca PM, Polosan M, Roux P, Samalin L, Schwan R; FondaMental Academic Centers of Expertise in Bipolar Disorders (FACE-BD) Collaborators; Leboyer M, Etain B. Godin O, et al. Among authors: aouizerate b. Acta Psychiatr Scand. 2024 Mar;149(3):207-218. doi: 10.1111/acps.13655. Epub 2024 Jan 24. Acta Psychiatr Scand. 2024. PMID: 38268142
Subjects suffering from bipolar disorder taking lithium are less likely to report physical pain: a FACE-BD study.
Risch N, Dubois J, Etain B, Aouizerate B, Bellivier F, Belzeaux R, Dubertret C, Haffen E, Januel D, Leboyer M, Lefrere A, Samalin L, Polosan M, Rey R, Roux P, Schwan R, Walter M; FondaMental Advanced Centres of Expertise in Bipolar Disorders (FACE-BD) Collaborators; Courtet P, Olié E. Risch N, et al. Among authors: aouizerate b. Eur Psychiatry. 2023 Dec 13;67(1):e8. doi: 10.1192/j.eurpsy.2023.2476. Eur Psychiatry. 2023. PMID: 38086540 Free PMC article.
Indirect effect of impulsivity on suicide risk through self-esteem and depressive symptoms in a population with treatment-resistant depression: A FACE-DR study.
Salles J, Stephan F, Molière F, Bennabi D, Haffen E, Bouvard A, Walter M, Allauze E, Llorca PM, Genty JB, Leboyer M, Holtzmann J, Nguon AS, D'Amato T, Rey R, Horn M, Vaiva G, Fond G, Richieri R, Hennion V, Etain B, El-Hage W, Camus V; FondaMental Advanced Centers of Expertise in Resistant Depression (FACE-DR) collaborators; Courtet P, Aouizerate B, Yrondi A. Salles J, et al. Among authors: aouizerate b. J Affect Disord. 2024 Feb 15;347:306-313. doi: 10.1016/j.jad.2023.11.063. Epub 2023 Nov 20. J Affect Disord. 2024. PMID: 37992775
Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset.
Misdrahi D, Dupuy M, Dansou Y, Boyer L, Berna F, Capdevielle D, Chereau I, Coulon N, D'Amato T, Dubertret C, Leignier S, Llorca PM, Lançon C, Mallet J, Passerieux C, Pignon B, Rey R, Schürhoff F, Swendsen J, Urbach M, Szöke A, Godin O, Fond G; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group. Misdrahi D, et al. Transl Psychiatry. 2023 Nov 7;13(1):341. doi: 10.1038/s41398-023-02640-x. Transl Psychiatry. 2023. PMID: 37935695 Free PMC article.
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort.
Vidal N, Brunet-Gouet E, Frileux S, Aouizerate B, Aubin V, Belzeaux R, Courtet P, D'Amato T, Dubertret C, Etain B, Haffen E, Januel D, Leboyer M, Lefrere A, Llorca PM, Marlinge E, Olié E, Polosan M, Schwan R, Walter M; FACE-BD (FondaMental Academic Centers of Expertise for Bipolar Disorders) group; Passerieux C, Roux P. Vidal N, et al. Among authors: aouizerate b. Eur Neuropsychopharmacol. 2023 Dec;77:67-79. doi: 10.1016/j.euroneuro.2023.08.502. Epub 2023 Sep 21. Eur Neuropsychopharmacol. 2023. PMID: 37741163 Review.
186 results